Using GLP-1s for any eating disorders, including anorexia, bulimia or binge eating disorder, is not medically recommended
However, patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 should avoid all GLP-1 and GIP agonists entirely
Naltrexone/bupropion (Mysimba), another UK-licensed option, can increase both blood pressure and heart rate and requires cardiovascular monitoring
The time it takes to create a website depends on various factors
Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-nave people with type 2 diabetes: the DUAL IV trial
During this step, your insurance will be verified